PTGX

Protagonist Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD138.31

+4.04 (+3.01%)

Rating:C-

Company Profile

CEO

Dinesh V. Patel

IPO Date

2016-08-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$133.80

Prev. Close

$134.27

Day Low

$131.05

Day High

$139.72

52W Low

$50.48

52W High

$143.29

Market Cap

$8.89B

Volume

0.56M

News SentimentBullish

Articles

Avg Positive

31.0%

Avg Negative

1.7%

Avg Neutral

67.1%

News Feed

Protagonist Therapeutics Announces Amendment of Agreement with Janssen Biotech for the Continued Development and Commercialization of IL-23 Antagonists

PRNewsWire·7/28/2021·↑ positive

Protagonist Therapeutics, Inc. Announces Closing of $132.2 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

PRNewsWire·6/18/2021·↓ negative